可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301087 可孚医疗

已收盘 05-17 15:00:00

{"stockData":{"symbol":"301087","market":"SZ","secType":"STK","nameCN":"可孚医疗","latestPrice":38.15,"timestamp":1715929425000,"preClose":38.18,"halted":0,"volume":950580,"delay":0,"floatShares":90574300,"shares":209000000,"eps":1.0562,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"05-17 15:00:00","open":38.19,"high":38.4,"low":37.63,"amount":36057700,"amplitude":0.0202,"askPrice":38.24,"askSize":155,"bidPrice":38.15,"bidSize":106,"shortable":0,"etf":0,"ttmEps":1.0562,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":38.18,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":42,"lowLimit":34.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":209238250,"pbRate":1.61,"roa":"--","roe":"2.05%","epsLYR":1.24,"committee":-0.125581,"marketValue":7982000000,"floatMarketCap":3455000000,"peRate":36.120052,"changeRate":-0.0008,"turnoverRate":0.0105,"status":1},"requestUrl":"/m/hq/s/301087","defaultTab":"news","newsList":[{"id":"2434871693","title":"可孚医疗新注册《电子血压计软件（腕式）V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2434871693","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434871693?lang=zh_cn&edition=full","pubTime":"2024-05-12 00:52","pubTimestamp":1715446326,"startTime":"0","endTime":"0","summary":"证券之星消息，近日可孚医疗（301087）新注册了《电子血压计软件（腕式）V1.0》项目的软件著作权。今年以来可孚医疗新注册软件著作权2个，较去年同期增加了100%。结合公司2023年年报财务数据，2023年公司在研发方面投入了1.14亿元，同比减3.46%。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051200000244.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434291908","title":"可孚医疗：截至2024年4月30日，公司股东总户数约1.8万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2434291908","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434291908?lang=zh_cn&edition=full","pubTime":"2024-05-11 19:02","pubTimestamp":1715425335,"startTime":"0","endTime":"0","summary":"证券之星消息，可孚医疗05月11日在投资者关系平台上答复投资者关心的问题。投资者：请问咱司截止2024年4月30日收盘股东人数是多少?截至2024年4月30日，公司股东总户数约1.8万户，感谢您的关注！投资者：董秘你好:从我司财报看，以2023年为例，每季度销售基本都在7、8亿元，毛利率也没明显变化，但是净利润却相差很多，一季度最高，二三四季度逐季减少，四季度最低，请问这种情况是什么原因？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051100018733.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432182690","title":"可孚医疗获得发明专利授权：“一种低噪声分子筛式制氧机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2432182690","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432182690?lang=zh_cn&edition=full","pubTime":"2024-05-04 02:08","pubTimestamp":1714759735,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示可孚医疗新获得一项发明专利授权，专利名为“一种低噪声分子筛式制氧机”，专利申请号为CN202210216679.2，授权日为2024年5月3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050400001111.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431087782","title":"【私募调研记录】磐耀资产调研蓝帆医疗、可孚医疗等7只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2431087782","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431087782?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:01","pubTimestamp":1714435261,"startTime":"0","endTime":"0","summary":"根据市场公开信息及4月29日披露的机构调研信息，知名私募磐耀资产近期对7家上市公司进行了调研，相关名单如下：1）蓝帆医疗 个股亮点：蓝帆转债于2020-06-19上市；公司有专业的医疗防护手套及口罩。2）可孚医疗 个股亮点：公司顺应新零售模式下大众医疗健康产品消费的需要,成为较早从事互联网医疗器械经营的公司之一，线上销售商品占比超70%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024043000014097.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431924138","title":"可孚医疗获信达证券买入评级，五大产品线均衡发展，听力保健成长可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2431924138","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431924138?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:04","pubTimestamp":1714406672,"startTime":"0","endTime":"0","summary":"4月29日，可孚医疗获信达证券买入评级，近一个月可孚医疗获得2份研报关注。研报预计2024-2026年营业收入分别为34.02亿元、44.14亿元、56.87亿元，同比增速分别为19.2%、29.8%、28.8%，实现归母净利润为3.43亿元、4.58亿元、6.06亿元，同比分别增长35.1%、33.3%、32.3%。健耳听力业务作为公司的重要板块，凭借门店拓展及市场需求恢复，营业收入实现显著增长，预计未来业务有望持续成长，为公司提供成长动力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300004348b62c3f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300004348b62c3f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431895543","title":"信达证券：给予可孚医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431895543","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431895543?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:16","pubTimestamp":1714403770,"startTime":"0","endTime":"0","summary":"信达证券股份有限公司唐爱金,曹佳琳近期对可孚医疗进行研究并发布了研究报告《五大产品线均衡发展，听力保健成长可期》，本报告对可孚医疗给出买入评级，当前股价为38.16元。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923171287bff00d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923171287bff00d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431027803","title":"可孚医疗：4月28日接受机构调研，包括知名机构盘京投资，趣时资产，磐耀资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2431027803","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431027803?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:55","pubTimestamp":1714362918,"startTime":"0","endTime":"0","summary":"2023 年实现自产产品收入 15.33 亿元，占主营业务收入比例为 56.66%。可孚医疗2024年一季报显示，公司主营收入8.07亿元，同比下降5.64%；归母净利润1.01亿元，同比下降24.75%；扣非净利润9178.42万元，同比下降26.55%；负债率22.82%，投资收益-43.17万元，财务费用-545.82万元，毛利率49.83%。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900008060.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431073340","title":"【调研快报】可孚医疗接待鹏华基金等多家机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2431073340","media":"东方财富","top":-1,"share":"https://www.laohu8.com/m/news/2431073340?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:16","pubTimestamp":1714360560,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！可孚医疗4月29日发布消息，4月28日，公司接待鹏华基金等多家机构调研，接待人员董事长、总裁张敏，董事、副总裁、董事会秘书薛小桥，副总裁、财务总监陈望朋，接待地点可孚医疗会议室。调研主要内容1、公司线上营销的主要模式和费用支出情况是怎样的?答:2023年线上收入18.27亿元，占主营业务收入67.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-29/doc-inatnimz3138322.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-29/doc-inatnimz3138322.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430032159","title":"可孚医疗(301087.SZ)发布2023年度业绩，净利润2.54亿元 同比减少15.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430032159","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430032159?lang=zh_cn&edition=full","pubTime":"2024-04-28 18:14","pubTimestamp":1714299266,"startTime":"0","endTime":"0","summary":"智通财经APP讯，可孚医疗(301087.SZ)发布2023年度业绩报告，报告期内公司实现营业收入28.54亿元，同比减少4.14%;归属于上市公司股东的净利润2.54亿元，同比减少15.71%;归属于上市公司股东的扣除非经常性损益的净利润2.01亿元，同比减少18.56%;基本每股收益1.24元，公司拟向全体股东每 10 股派发现金红利 12 元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113495.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430031095","title":"图解可孚医疗一季报：第一季度单季净利润同比减24.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430031095","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430031095?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:43","pubTimestamp":1714297382,"startTime":"0","endTime":"0","summary":"证券之星消息，可孚医疗2024年一季报显示，公司主营收入8.07亿元，同比下降5.64%；归母净利润1.01亿元，同比下降24.75%；扣非净利润9178.42万元，同比下降26.55%；负债率22.82%，投资收益-43.17万元，财务费用-545.82万元，毛利率49.83%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800006350.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430367220","title":"可孚医疗最新公告：一季度净利润1.01亿元 同比下降24.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430367220","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430367220?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:15","pubTimestamp":1714295712,"startTime":"0","endTime":"0","summary":"可孚医疗发布2024年第一季度报告，实现营业收入8.07亿元，同比下降5.64%；归属于上市公司股东的净利润1.01亿元，同比下降24.75%；基本每股收益0.5元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800005564.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430036786","title":"可孚医疗(301087)3月31日股东户数1.96万户，较上期减少1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430036786","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430036786?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:11","pubTimestamp":1714295472,"startTime":"0","endTime":"0","summary":"证券之星消息，近日可孚医疗披露，截至2024年3月31日公司股东户数为1.96万户，较3月29日减少353.0户，减幅为1.77%。在医疗器械行业个股中，可孚医疗股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.1万户。从股价来看，2024年3月29日至2024年3月31日，可孚医疗区间跌幅为0.0%，在此期间股东户数减少353.0户，减幅为1.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800005387.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430584033","title":"图解可孚医疗年报：第四季度单季净利润同比减90.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430584033","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430584033?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:45","pubTimestamp":1714293915,"startTime":"0","endTime":"0","summary":"证券之星消息，可孚医疗2023年年报显示，公司主营收入28.54亿元，同比下降4.14%；归母净利润2.54亿元，同比下降15.71%；扣非净利润2.01亿元，同比下降18.56%；其中2023年第四季度，公司单季度主营收入7.3亿元，同比下降33.61%；单季度归母净利润1232.35万元，同比下降90.82%；单季度扣非净利润682.33万元，同比下降95.04%；负债率21.4%，投资收益4771.51万元，财务费用-1906.19万元，毛利率43.28%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800004029.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2421014371","title":"可孚医疗(301087.SZ)授出633.3万股限制性股票 授予价为16.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2421014371","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2421014371?lang=zh_cn&edition=full","pubTime":"2024-03-21 20:01","pubTimestamp":1711022460,"startTime":"0","endTime":"0","summary":"可孚医疗(301087.SZ)公告，公司《2024年限制性股票激励计划(草案)》规定的首次授予条件已经成就，根据公司2024年第一次临时股东大会授权，公司于2024年3月21日召开的第二届董事会第八次会议和第二届监事会第八次会议审议通过了《关于向激励对象首次授予限制性股票的议案》，同意以2024年3月21日为首次授予日，向符合条件的339名激励对象授予633.30万股限制性股票，限制性股票授予价格为16.60元/股。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-21/doc-inapaxhk7036835.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-21/doc-inapaxhk7036835.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2395516088","title":"可孚医疗(301087.SZ)完成回购2.01%股份 耗资1.56亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2395516088","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2395516088?lang=zh_cn&edition=full","pubTime":"2023-12-29 17:21","pubTimestamp":1703841660,"startTime":"0","endTime":"0","summary":"可孚医疗(301087.SZ)公告，截至2023年12月28日，公司回购计划已实施完毕。公司实际回购时间区间为2023年1月6日至11月9日。公司累计回购股份420.24万股，占公司总股本的2.01%，最高成交价为39.77元/股，最低成交价为36.00元/股，成交总金额为1.56亿元(不含交易费用)。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-29/doc-imzzsqhy3543558.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-29/doc-imzzsqhy3543558.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-10-25","address":"湖南省长沙市雨花区振华路816号","stockEarnings":[{"period":"1week","weight":-0.0026},{"period":"1month","weight":0.082},{"period":"3month","weight":0.1753},{"period":"6month","weight":-0.025},{"period":"1year","weight":-0.1937},{"period":"ytd","weight":0.0066}],"companyName":"可孚医疗科技股份有限公司","boardCode":"AI0035","perCapita":"5031股","boardName":"专用设备制造业","registeredCapital":"20923万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　可孚医疗科技股份有限公司是一家国内领先的大型、综合性家用医疗器械企业，专业从事医疗器械的研发、生产、销售和服务。公司的主要产品包括血压计、血糖仪、红外体温计、轮椅、护理床、助行器、助听器、无创呼吸机、制氧机、雾化器艾灸系列、按摩牵引类、健康防护耗材等。公司在技术工艺方面先后获得了“长沙市智能制造试点企业”、“湖南省高新技术企业”、“长沙市企业技术中心”等荣誉，公司自主研发的助听器、听力计、血压计、雾化器等产品处于国内领先水平。","serverTime":1716057299570,"listedPrice":93.09,"stockholders":"18000人(较上一季度减少8.38%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供可孚医疗(301087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"可孚医疗,301087,可孚医疗股票,可孚医疗股票老虎,可孚医疗股票老虎国际,可孚医疗行情,可孚医疗股票行情,可孚医疗股价,可孚医疗股市,可孚医疗股票价格,可孚医疗股票交易,可孚医疗股票购买,可孚医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供可孚医疗(301087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}